BioCryst Pharmaceuticals, Inc. (BCRX)

7.52 +0.07 (+0.94%) USD  |  NASDAQ  |  Feb 23, 09:45
More

BioCryst Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
KalVista Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Protokinetix, Inc. --